Novavax’s COVID-19 vaccine 96.4 per cent effective against virus in phase-3 trial
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read more
New York: US-based biotech company Novavax's COVID-19 vaccine was 96.4 per cent effective against original strain of the virus in ...
Read more
There is bad news from Italy. The Far-Right government of Giorgia Meloni is virtually gagging the media and using the...
Read more
Chinese President Xi Jinping’s recent tour of Europe - first in five years – is being regarded as an opportunity...
Read more
A disconcerting new report has revealed that if business continues as usual on the front of carbon dioxide emissions, India...
Read more
Arvind Kejriwal has been released for a few days to campaign, after which he has to return to jail. He...
Read more